PDF herunterladen
Clin Colon Rectal Surg 2009; 22(2): 077-083
DOI: 10.1055/s-0029-1223838
© Thieme Medical Publishers

Epidermoid Cancers of the Anal Canal: Current Treatment

Jennifer Blumetti1 , Amir L. Bastawrous1 , 2
  • 1Division of Colon and Rectal Surgery, Department of Surgery, University of Illinois at Chicago, Chicago, Illinois
  • 2Stroger Hospital of Cook County, Chicago, Illinois
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Mai 2009 (online)

    Lizenzen und Reprints

ABSTRACT

Epidermoid carcinoma of the anal canal is an uncommon disease, but has increased in incidence with the HIV epidemic. Prior to the 1970s, treatment consisted of radical surgery with abdominoperineal resection. With the pioneering work of Dr. Norman Nigro, this has shifted to a nonsurgical approach, with primary treatment consisting of multimodality therapy with radiation and chemotherapy. This review provides an overview of the historical, current, and future treatments of epidermoid anal canal malignancies.

KEYWORDS

Anal canal malignancy - epidermoid carcinoma - chemoradiation - Nigro protocol

REFERENCES

  • 1 Mahmoud N N, Madoff R D. Investigation and management of malignant anal-canal tumours. In: Beynon J, Carr ND Progress in Colorectal Surgery. New York; Springer-Verlag 2005: 115-134
    Google Scholar
  • 2 Klas J V, Rothenberger D A, Wong W D, Madoff R D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.  Cancer. 1999;  85(8) 1686-1693
    CrossrefPubMedGoogle Scholar
  • 3 Whiteford M H, Stevens Jr K R, Oh S, Deveney K E. The evolving treatment of anal cancer: how are we doing?.  Arch Surg. 2001;  136(8) 886-891
    PubMedGoogle Scholar
  • 4 Wong S, Gibbs P, Chao M et al.. Carcinoma of the anal canal: a local experience and review of the literature.  ANZ J Surg. 2004;  74(7) 541-546
    CrossrefPubMedGoogle Scholar
  • 5 Lopez M J, Myerson R J, Shapiro S J et al.. Squamous cell carcinoma of the anal canal.  Am J Surg. 1991;  162(6) 580-584
    CrossrefPubMedGoogle Scholar
  • 6 Skibber J M, Eng C. Colon, rectal and anal cancer management. In: Chang AS, Ganz PA, Hayes DF, et al Oncology, An Evidence Based Approach. New York; Springer-Verlag 2006: 704-732
    Google Scholar
  • 7 Salmon R J, Fenton J, Asselain B et al.. Treatment of epidermoid anal canal cancer.  Am J Surg. 1984;  147(1) 43-48
    CrossrefPubMedGoogle Scholar
  • 8 Mendenhall W M, Sombeck M D, Speer T W, Marsh R D, Carroll R R, Copeland III E M. Current management of squamous cell carcinoma of the anal canal.  Surg Oncol. 1994;  3(3) 135-146
    CrossrefPubMedGoogle Scholar
  • 9 Oehler-Jänne C, Huguet F, Provencher S et al.. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.  J Clin Oncol. 2008;  26(15) 2550-2557
    CrossrefPubMedGoogle Scholar
  • 10 Welton M L, Varma M G. Anal cancer. In: Wolff BG, Fleshman JW, Beck DE, et al The ASCRS Textbook of Colon and Rectal Surgery. New York; Springer-Verlag 2007: 482-500
    Google Scholar
  • 11 Golden G T, Horsley III J S. Surgical management of epidermoid carcinoma of the anus.  Am J Surg. 1976;  131(3) 275-280
    CrossrefPubMedGoogle Scholar
  • 12 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report 1974.  Dis Colon Rectum. 1993;  36 709-711
    CrossrefPubMedGoogle Scholar
  • 13 Nigro N D, Vaitkevicius V K, Buroker T, Bradley G T, Considine B. Combined therapy for cancer of the anal canal.  Dis Colon Rectum. 1981;  24(2) 73-75
    CrossrefPubMedGoogle Scholar
  • 14 Nigro N D, Seydel H G, Considine B, Vaitkevicius V K, Leichman L, Kinzie J J. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal.  Cancer. 1983;  51(10) 1826-1829
    CrossrefPubMedGoogle Scholar
  • 15 UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348(9034) 1049-1054
    CrossrefPubMedGoogle Scholar
  • 16 Bartelink H, Roelofsen F, Eschwege F et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15(5) 2040-2049
    PubMedGoogle Scholar
  • 17 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14(9) 2527-2539
    PubMedGoogle Scholar
  • 18 Grabenbauer G G, Kessler H, Matzel K E, Sauer R, Hohenberger W, Schneider I HF. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.  Dis Colon Rectum. 2005;  48(9) 1742-1751
    CrossrefPubMedGoogle Scholar
  • 19 Gretschel S, Warnick P, Bembenek A et al.. Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canal.  Eur J Surg Oncol. 2008;  34(8) 890-894
    PubMedGoogle Scholar
  • 20 Salama J K, Mell L K, Schomas D A et al.. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.  J Clin Oncol. 2007;  25(29) 4581-4586
    CrossrefPubMedGoogle Scholar
  • 21 Ajani J A, Winter K A, Gunderson L L et al.. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.  JAMA. 2008;  299(16) 1914-1921
    CrossrefPubMedGoogle Scholar
  • 22 Glynne-Jones R, Meadows H, Wan S National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group et al. EXTRA—a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.  Int J Radiat Oncol Biol Phys. 2008;  72(1) 119-126
    CrossrefPubMedGoogle Scholar
  • 23 James R, Meadows H, Wan S. ACT II: the second UK phase III anal cancer trial.  Clin Oncol (Royal College of Radiologists). , Editorial 2005;  17 364-366
    CrossrefPubMedGoogle Scholar
  • 24 Glynne-Jones R, Mawdsley S. Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?.  J Clin Oncol. 2008;  26(22) 3669-3671
    CrossrefPubMedGoogle Scholar
  • 25 Fleshner P R, Chalasani S, Chang G J, Levien D H, Hyman N H, Buie W D. Standards Practice Task Force, American Society of Colon and Rectal Surgeons . Practice parameters for anal squamous neoplasms.  Dis Colon Rectum. 2008;  51(1) 2-9
    CrossrefPubMedGoogle Scholar
  • 26 Deniaud-Alexandre E, Touboul E, Tiret E et al.. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.  Int J Radiat Oncol Biol Phys. 2003;  56(5) 1259-1273
    CrossrefPubMedGoogle Scholar
  • 27 Mullen J T, Rodriguez-Bigas M A, Chang G J et al.. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.  Ann Surg Oncol. 2007;  14(2) 478-483
    CrossrefPubMedGoogle Scholar
  • 28 Roohipour R, Patil S, Goodman K A et al.. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.  Dis Colon Rectum. 2008;  51(2) 147-153
    CrossrefPubMedGoogle Scholar
  • 29 Renehan A G, Saunders M P, Schofield P F, O'Dwyer S T. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer.  Br J Surg. 2005;  92(5) 605-614
    CrossrefPubMedGoogle Scholar
  • 30 Akbari R P, Paty P B, Guillem J G et al.. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.  Dis Colon Rectum. 2004;  47(7) 1136-1144
    CrossrefPubMedGoogle Scholar
  • 31 Papaconstantinou H T, Bullard K M, Rothenberger D A, Madoff R D. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity.  Colorectal Dis. 2006;  8(2) 124-129
    CrossrefPubMedGoogle Scholar
  • 32 Nilsson P J, Svensson C, Goldman S, Ljungqvist O, Glimelius B. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols.  Int J Radiat Oncol Biol Phys. 2005;  61(1) 92-102
    CrossrefPubMedGoogle Scholar
  • 33 Gerard J P, Chapet O, Samiei F et al.. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature.  Cancer. 2001;  92(1) 77-84
    CrossrefPubMedGoogle Scholar
  • 34 Swan M C, Furniss D, Cassell O CS. Surgical management of metastatic inguinal lymphadenopathy.  BMJ. 2004;  329(7477) 1272-1276
    CrossrefPubMedGoogle Scholar
  • 35 Wexler A, Berson A M, Goldstone S E et al.. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2008;  51(1) 73-81
    CrossrefPubMedGoogle Scholar
  • 36 Blazy A, Hennequin C, Gornet J M et al.. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2005;  48(6) 1176-1181
    CrossrefPubMedGoogle Scholar
  • 37 Place R J, Gregorcyk S G, Huber P J, Simmang C L. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.  Dis Colon Rectum. 2001;  44(4) 506-512
    CrossrefPubMedGoogle Scholar
  • 38 Stadler R F, Gregorcyk S G, Euhus D M, Place R J, Huber P J, Simmang C L. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2004;  47(8) 1305-1309
    CrossrefPubMedGoogle Scholar

Amir L BastawrousM.D. 

Stroger Hospital of Cook County, Cook County Admin. Bldg.

1900 W. Polk St., #401, Chicago, IL 60612-3736

eMail: bastawro@uic.edu

      >